Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc. (PSBD) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Palmer Square Capital BDC Inc. (PSBD), covering cash flow, earnings, and balance sheets.
Palmer Square Capital BDC Inc. (PSBD) Income Statement & Financial Overview
Review Palmer Square Capital BDC Inc. PSBD income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $31.21M | $35.36M | $30.19M | $27.14M |
| Cost of Revenue | $17.15M | $14.16M | $4.65M | $4.70M |
| Gross Profit | $14.07M | $13.27M | $25.53M | $22.44M |
| Gross Profit Ratio | $0.45 | $0.38 | $0.85 | $0.83 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $805271.00 | $1.35M | $1.25M | $1.09M |
| Operating Expenses | $1.15M | $1.35M | $8.81M | $1.09M |
| Total Costs & Expenses | $18.30M | $15.51M | $8.81M | $6.83M |
| Interest Income | $574336.00 | $33.93M | $35.98M | $35.46M |
| Interest Expense | $12.97M | $14.16M | $15.67M | $15.00M |
| Depreciation & Amortization | $0.00 | $0.00 | $6.50M | $0.00 |
| EBITDA | $25.88M | $26.08M | $23.23M | $20.31M |
| EBITDA Ratio | $0.83 | $0.74 | $0.77 | $0.75 |
| Operating Income | $12.91M | $11.92M | $16.72M | $20.31M |
| Operating Income Ratio | $0.41 | $0.34 | $0.55 | $0.75 |
| Other Income/Expenses (Net) | $279.00 | $0.00 | -$9.17M | -$15.00M |
| Income Before Tax | $12.91M | $11.92M | $7.56M | $5.31M |
| Income Before Tax Ratio | $0.41 | $0.34 | $0.25 | $0.20 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $12.91M | $11.92M | $7.56M | $5.31M |
| Net Income Ratio | $0.41 | $0.34 | $0.25 | $0.20 |
| EPS | $0.40 | $0.37 | $0.23 | $0.16 |
| Diluted EPS | $0.40 | $0.37 | $0.23 | $0.16 |
| Weighted Avg Shares Outstanding | $32.60M | $32.61M | $32.61M | $32.57M |
| Weighted Avg Shares Outstanding (Diluted) | $32.60M | $32.61M | $32.61M | $32.57M |
Over the past four quarters, Palmer Square Capital BDC Inc. demonstrated steady revenue growth, increasing from $27.14M in Q2 2024 to $31.21M in Q1 2025. Operating income reached $12.91M in Q1 2025, maintaining a consistent 41% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $25.88M, reflecting operational efficiency. Net income rose to $12.91M, with EPS at $0.40. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan